Arrowhead receives $100 million milestone from Sarepta for ARO-DM1 study
Go back to Arrowhead receives $100 million milestone from Sarepta for ARO-DM1 study| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 74.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.11 | 52 Week High | $8.22 | |||
| Open | $74.11 | 52 Week Low | $3.07 | |||
| Day High | $74.11 | P/E | N/A | |||
| Day Low | $74.11 | EPS | $-1.30 | |||
| Volume | 1,459 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 18.82 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.82 | 52 Week High | $63.73 | |||
| Open | $18.82 | 52 Week Low | $8.00 | |||
| Day High | $18.82 | P/E | N/A | |||
| Day Low | $18.82 | EPS | $-5.69 | |||
| Volume | 1,326 | |||||
